Evidence map›Paper›PMID 36462046›Full record

ArticleEuropean radiology2023

Extracellular volume fraction determined by equilibrium contrast-enhanced CT for the prediction of the pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

Yuesheng Luo, Leilei Liu, Daihong Liu, Hesong Shen, Xiaoxia Wang, Chunbo Fan, Zhen Zeng, Jing Zhang, Yong Tan, Xiaoyue Zhang and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Yuesheng LuoDepartment of Radiology, Chongqing University Cancer Hospital, School of Medicine, Chongqing University, Chongqing, 400030, People's Republic of China.
Leilei LiuDepartment of Radiology, Chongqing University Cancer Hospital, School of Medicine, Chongqing University, Chongqing, 400030, People's Republic of China.
Daihong LiuDepartment of Radiology, Chongqing University Cancer Hospital, School of Medicine, Chongqing University, Chongqing, 400030, People's Republic of China.
Hesong ShenDepartment of Radiology, Chongqing University Cancer Hospital, School of Medicine, Chongqing University, Chongqing, 400030, People's Republic of China.
Xiaoxia WangDepartment of Radiology, Chongqing University Cancer Hospital, School of Medicine, Chongqing University, Chongqing, 400030, People's Republic of China.
Chunbo FanCancer Radiotherapy Center, Chongqing University Cancer Hospital, School of Medicine, Chongqing University, Chongqing, 400030, People's Republic of China.
Zhen ZengDepartment of Pathology, Chongqing University Cancer Hospital, School of Medicine, Chongqing University, Chongqing, 400030, People's Republic of China.
Jing ZhangDepartment of Radiology, Chongqing University Cancer Hospital, School of Medicine, Chongqing University, Chongqing, 400030, People's Republic of China.
Yong TanDepartment of Radiology, Chongqing University Cancer Hospital, School of Medicine, Chongqing University, Chongqing, 400030, People's Republic of China.
Xiaoyue ZhangSiemens Healthineers, Xi'an, 710000, People's Republic of China.
Jiaxing WuSiemens Healthineers, Shanghai, 200126, People's Republic of China.
Jiuquan ZhangDepartment of Radiology, Chongqing University Cancer Hospital, School of Medicine, Chongqing University, Chongqing, 400030, People's Republic of China. zhangjq_radiol@foxmail.com.ORCID http://orcid.org/0000-0003-0239-6988
Chongqing University · CNSiemens (China) · CN

Funding

2020 SKY Imaging Research Fund of the Chinese International Medical Foundation Z-2014-07-2003-24Chongqing Medical Research Project of Combination of Science and Medicine 2021MSXM035Chongqing Natural Science Foundation cstc2021jcyj-msxmX0313Medical Scientific Research Project of Chongqing Municipal Health Commission 2022WSJK027Natural Science Foundation of Chongqing municipality cstc2021jcyj-msxmX0387
6 · The paper itself

Abstract

objectivesTo determine the extracellular volume (ECV) fraction derived from equilibrium contrast-enhanced CT for predicting pathological complete response (pCR) after neoadjuvant chemoradiotherapy (NCRT) in locally advanced rectal cancer (LARC).

methodsThe ECV fraction before NCRT (ECV

conclusionsECV KEY POINTS: • ECV

Indexed as

Neoplasms, Second PrimaryRectal NeoplasmsChemoradiotherapyHumansNeoadjuvant TherapyTomography, X-Ray ComputedTreatment OutcomeNeoadjuvant therapyRectal neoplasmsTomography, X-ray computed

Identifiers

PMID36462046
OpenAlexW4310642525

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.